Upregulation of CCAR2 is associated with short overall survival and relapse-free survival in various human cancers, suggesting that CCAR2 can be used as a prognostic marker for the survival of cancer patients and as a novel target for cancer therapy. This evidence concerns the gene CCAR2 and cancer.